trending Market Intelligence /marketintelligence/en/news-insights/trending/sfqef2dzd-wkunyds4pxng2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

DOJ clears CVS-Aetna deal pending Medicare Part D divestiture

Infrastructure Issues: Tools to Dig Deep on Potential Risks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

DOJ clears CVS-Aetna deal pending Medicare Part D divestiture

The primary U.S. antitrust regulator indicated it will approve of CVS Health Corp.'s pending $69 billion deal to acquire Aetna Inc. once both companies divest their Medicare Part D plans.

The Department of Justice wrote in a news release that the divestiture would "fully resolve the Department's competition concerns" related to the planned tie-up.

The release confirms earlier reports that the Justice Department was inclined to require both companies to off-load their Part D business.

Medicare Part D is private Medicare insurance that covers only drug benefits.

WellCare Health Plans Inc. agreed in September to acquire Aetna's Part D plans, effective Dec. 31.

"We are pleased to have reached an agreement with the DOJ that maintains the strategic benefits and value creation potential of our combination with Aetna," CVS Health President and CEO Larry Merlo wrote in a statement. "We are now working to complete the remaining state reviews."